Vyvanse is a new class of ADHD medication for your patients 6 to 12 years of age. It is a therapeutically inactive molecule that is converted to its active form by natural metabolic processes.
Vyvanse:

*Vyvanse (lisdexamfetamine dimesylate) is recognized as a new chemical entity
Next: ADHD Symptom Improvement ![]()
Adderall® is a registered trademark of Shire LLC, under license to Duramed Pharmaceuticals, Inc.
Adderall XR® is a registered trademark of Shire LLC.
Concerta® is a registered trademark of ALZA Corporation.
Daytrana® is a trademark of Shire Pharmaceuticals Ireland Ltd.
Focalin® and Focalin® XR are trademarks of Novartis Pharmaceuticals Corp.
Metadate CD™ is a registered trademark of UCB. Inc.
Ritalin® and Ritalin LA® are registered trademarks of Novartis Pharmaceuticals Corp.
Strattera® is a registered trademark of Eli Lilly and Company.
Home | About Vyvanse | How Vyvanse Works | Vyvanse Clinical Studies | Professional Resources and Tools
Support for Your Patients | Join VyvansePRO | Privacy Policy | Unsubscribe
Vyvanse Full Prescribing Information | Vyvanse Medication Guide | Vyvanse Important Safety Information
Adderall XR Full Prescribing Information | Adderall XR Medication Guide | Adderall XR Important Safety Information
|
|
|
| © 2008 Shire US Inc Wayne, PA 19087-5637 (800) 828-2088. All Rights reserved. This site is strictly intended for U.S. residents and is governed solely by U.S. laws and governmental regulations. Please see our online privacy policy for more information. While Shire US Inc. makes reasonable efforts to include accurate, up-to-date information on the site, Shire US Inc. assumes no liability for any errors or ommissions in the content of the site. |
LDX2005 | 04/08 |